+ T cells could make an important contribution to protection against tuberculosis (TB), but the antigenic determinants recognized in the context of major histocompatibility complex class I molecules remain ill defined. Our aim was to identify nonamer peptides derived from the acr/16-kDa antigen. Two immunogenic peptides (p21-29 and p120-128) were identified by their ability to elicit cytotoxic CD8 + T cells from juvenile patients recovering from TB. Epitopespecific recognition was demonstrated by the lysis of both Mycobacterium tuberculosis-infected and peptide-pulsed macrophages, the release of cytotoxic granules, and interferon-g and tumor necrosis factor-a production. CD8 + T cell responses to p21-29 and p120-128 were detected ex vivo in freshly isolated peripheral blood mononuclear cells from patients with TB but not in those from healthy control subjects. Our data suggest that these antigenic peptides can play a critical role in effective immunity against mycobacterial infection and TB.
of M. tuberculosis, on the basis of the MHC class I HLA-A*0201-binding motif. HLA-A*0201 frequency is 29% in the white population. The 16-kDa antigen was selected because this protein is predominantly expressed by M. tuberculosis during stationary growth or when the organism is subjected to oxygen deprivation, and it can account for as much as 25% of total bacillary protein expression under these circumstances. Because containment within the granuloma may induce similar conditions, the 16-kDa protein may be an important antigenic target during bacillary latency [7] . In addition, we have found that postchemotherapy changes in T cell proliferative and IFN-g responses in patients with TB are particularly striking in CD4 ϩ T cells that recognize the 16-kDa protein [8] .
The present article reports the identification of two 16-kDa peptide epitopes recognized by CD8 ϩ T cells from individuals with HLA-A*0201. These CD8 ϩ T cells produce IFN-g and TNF-a, express perforin and granulysin, and perform cytolytic functions directed against M. tuberculosis-infected macrophages.
Subjects, Materials, and Methods
Human subjects. Peripheral blood was obtained from 8 children with HLA-A*0201 who had tuberculous infection (5 boys and 3 girls; age range, 6-12 years) from the Children's Hospital G. Di Cristina, Palermo, Italy. The subjects had pulmonary TB, as established by the presence of clinical symptoms of TB, positive results of tuberculin (purified protein derivative; PPD) skin testing, and signs visible on chest radiography. All patients included in this study had a positive PPD skin test. None of the children had been vaccinated in infancy with bacille Calmette-Guérin (BCG), had evidence of human immunodeficiency virus infection, or were being treated with steroid or antituberculosis drugs at the time of sam- pling. PPD skin tests were considered to be positive when the induration diameter was 15 mm at 72 h after injection of 1 U of PPD (Statens Seruminstitut).
Subjects underwent serologic HLA typing. Presence of the HLA subtype A*0201 was confirmed by a polymerase chain reaction amplification technique that used sequence-specific oligonucleotide primers.
Synthetic peptides and cell lines. A total of 5 nonamer peptides derived from the sequence of the 16-kDa protein of M. tuberculosis and containing HLA-A*0201-binding motifs [9] were prepared using solid-phase/Fmoc chemistry, as described in detail elsewhere [8] . The peptides were of 90% purity, and their homogeneity was confirmed by analytical reverse-phase high-performance liquid chromatography, mass spectroscopy, and amino acid composition analysis. The sequences of the peptides were SLFPEFSEL (p13-21), LFAAFPSFA (p21-29), EMKEGRYEV (p45-53), GAVED-DIKA (p107-115), and GILTVSVAV (p120-128).
Epstein-Barr virus-transformed homozygous lymphoblastoid B (EBV-B) cell lines were obtained from the Istituto Tumori Genova, Genoa, Italy; the HLA types of these cells are shown in table 1. The HLA-A2-positive, premyelomonocytic cell line THP-1 was also obtained from the Istituto Tumori Genova.
Isolation of CD8 ϩ T cells. PBMC were isolated from heparinized blood by centrifugation on Ficoll-Paque (Pharmacia). Cells were maintained in RPMI 1640 medium (Gibco) supplemented with 10% heat-inactivated pooled human AB ϩ serum, 2 mM L-glutamine, 20 mM HEPES, 100 U/mL penicillin, 100 mg/mL streptomycin, M 2-mercaptoethanol, and 150 IU/mL recombinant inter-
Ϫ5
5 ϫ 10 leukin (IL)-2, hereafter referred to as "IL-2-supplemented culture medium" (IL-2/CM). CD8 ϩ T lymphocytes were sorted by immunomagnetic beads (Myltenyi Biotec) using an anti-CD8 monoclonal antibody (MAb; clone MEM31), and CD8 ϩ T cells were then expanded in vitro in IL-2/CM supplemented with purified phytohemagglutinin (leucoagglutinin, 0.5 mg/mL; Sigma) and irradiated (30 Gy from a cesium source) allogeneic feeder cells (peripheral blood lymphocytes and EBV-B cells at a ratio of 10:1) as described above. Cells were maintained for 3-4 weeks without restimulation before functional analysis was done. The purity of the CD8 ϩ T cells was assessed by 2-color flow cytometry. Phycoerythrin-conjugated anti-CD3 antibody was used with fluorescein isothiocyanate (FITC)-conjugated anti-CD8 (all from Becton Dickinson). The cells were analyzed by FACScan flow cytometer (Becton Dickinson). This T cell expansion procedure, in which phytohemagglutinin and allogeneic stimulation are used, induces expansion of virtually all CD8 ϩ T cells and does not introduce any bias in the T cell repertoire [10] .
Generation of CTL lines from healthy HLA-A*0201-positive donors by in vitro immunization. The method used for in vitro CTL induction followed the protocol of Plebanski et al. [11] , which provides, after 4 cycles of stimulation, 185% peptide-specific CTL. In brief, peripheral blood mononuclear cells (PBMC) from HLA-A*0201-positive donors were pulsed with 50 mg/mL peptides at cells in RPMI medium at 37ЊC for 90 min. These cells were 7 3 ϫ 10 washed and cultured at cells/well in complete medium. 6 3 ϫ 10 Every 3 days, the culture was refreshed by complete medium plus human recombinant IL-2 (40 U/mL). Cultures were restimulated weekly with peptide-pulsed irradiated autologous cells as feeders, as described elsewhere [10] . After 4-5 cycles of restimulation, CD4 ϩ T cells were depleted by immunomagnetic sorting, and the remaining enriched CD8 ϩ T cells (80%-90%) were restimulated weekly as described earlier.
In vitro stimulation of peptide-specific CD8 ϩ T cells. CD8 ϩ T cells ( ) were incubated with autologous or allogeneic cells 4 5 ϫ 10 in the presence of synthetic peptides at different concentrations. After 6 h, the supernatants were collected and stored at Ϫ70ЊC until testing. IFN-g and TNF-a levels were assessed by a 2-MAb sandwich ELISA kit (Euroclone).
Intracellular fluorescence-activated cell cytometry (FACS) analysis. CD8
ϩ T cells or fresh PBMC were stimulated with peptides, as described earlier, in the presence of monensin for 6 h at 37ЊC in 5% CO 2 ation was followed by permeabilization with PBS-1% FCS-0.3% saponin-0.1% sodium azide for 15 min at 4ЊC. Staining of intracellular cytokine was performed by incubation of fixed permeabilized cells with FITC-labeled anti-IFN-g antibody. Viable lymphocytes were gated by forward and side scatter, and analysis was performed on 100,000 acquired events for each sample.
For detection of granulysin and perforin, CD8 ϩ T cells were stimulated with peptides and autologous cells for 3 h. The cells were washed and fixed with PBS-4% paraformaldehyde for 30 min at 4ЊC. After 2 washes with permeabilization buffer (PBS-1% FCS-0.3% saponin-0.1% sodium azide), the cells were incubated with rabbit anti-perforin MAb (dG9 [Alexis]; final concentration, 2 mg/mL), mouse anti-granulysin MAb (DH-4; final concentration, 2 mg/mL), or an isotype-matched control MAb of irrelevant specificity for 1 h on ice in PBS-1% FCS. After 2 washes in PBS-1% FCS, cells were stained with QR-conjugated anti-human CD8, phycoerythrin-conjugated anti-rabbit IgG, and FITC-conjugated anti-mouse IgG. All the antibodies were purchased from Sigma. After 2 more washes in PBS-1% FCS, the cells were analyzed by FACS [12] .
Cytotoxicity assay. THP-1 target cells ( cells/well) were 3 4 ϫ 10 incubated with phorbol 12-myristate 13-acetate (Sigma) at a final concentration of 10 ng/mL in 96-well round-bottom plates for 24 h at 37ЊC in the presence of 5% CO 2 . Nonadherent cells were removed, and the macrophages were infected with an avirulent M. tuberculosis strain, H37Ra, or BCG (ratio of colony-forming units to macrophages, 10:1) for 24 h or pulsed with peptides for 6 h at 37ЊC in 5% CO 2 . The macrophages were washed with RPMI 1640 medium, and CTL effector cells were added at different ratio and incubated for 5 h at 37ЊC in 5% CO 2 . Cytotoxicity was analyzed using a nonradioactive colorimetric cytotoxicity assay (CytoTox 96; Promega).
Results

Identification of HLA-A*0201 peptides from M. tuberculosis 16-kDa protein.
Because HLA-A*0201 is one of the most prominent MHC class I HLA alleles, we selected potential candidate peptides within the sequences of the 16-kDa protein for the presence of allele-specific peptide motifs for the HLA-A*0201 molecules. This analysis was carried out using the SYF-PEITHI database for MHC ligand and peptide motifs [9] . From this analysis, a total of 50 sequences of 9 aa, with HLA-A*0201-binding scores ranging from 5 to 27, were found to contain the binding motifs for the HLA-A*0201 molecule. Five peptides were synthesized that corresponded to the candidate sequences and had a high probability, on the basis of score (!15), of being presented by the HLA-A*0201 molecule. These peptides were used in subsequent studies.
We analyzed the response to 16-kDa-derived peptides of CD8 ϩ T cells from 8 HLA-A*0201-positive patients with TB. For each patient, CD8
ϩ T cell lines were generated at the time of diagnosis, and the peptide recognition pattern was analyzed by measuring the amounts of TNF-a and IFN-g produced after stimulation with peptides and autologous PBMC. Figure 1 shows that responses to peptides p21-29 and p120-128 were detected in CD8 ϩ T cells from 8 of 8 patients with TB, whereas very low TNF-a production was observed after stimulation with peptides p13-21, p45-53, and p107-115. Similar data were obtained for IFN-g production (data not shown). The CD8 ϩ T cell response to peptides p21-29 and p120-128 was both 128 peptides was observed. Similarly, specific lysis was seen in THP-1 target cells infected with BCG or H37Ra (figure 3), whereas CD8 ϩ T cells failed to lyse either unpulsed or uninfected THP-1 cells. These results provide evidence that CD8 ϩ T cells are able to recognize peptides from mycobacterial antigens presented by monocyte-derived macrophages and to mediate cytolytic activity.
Characterization of CD8 ϩ CTL specific for mycobacterial 16-kDa peptides. To verify that CD8 ϩ T cell responses against p21-29 or p120-128 epitopes can also be induced in healthy subjects, CD8 ϩ T cell lines were obtained in vitro: PBMC from uninfected HLA-A*0201-positive donors were cultured and stimulated with autologous PBMC pulsed with either p21-29 or p120-128 peptides for 4-5 cycles, as described in Subjects, Materials, and Methods. Both T cell lines were able to kill, in an antigen-specific fashion, peptide-pulsed THP-1 cells ( figure  4A ). On stimulation with a specific peptide, CD8 ϩ T cell lines produced TNF-a and IFN-g ( figure 4B ). CD8
ϩ CTL specific for p21-29 and p120-128 peptides were further analyzed for the presence of intracellular IFN-g, perforin, and granulysin. Endogenous generation of p21-29 and p120-128 epitopes during mycobacterial infection. To demonstrate that p21-29 and p120-128 are endogenously generated epitopes, we infected THP-1 cells with BCG and measured recognition by peptidespecific CD8 ϩ T cell lines. Two T cell lines specific for either p21-29 or p120-128 peptides promptly secreted IFN-g and TNF-a in response to BCG-infected cells (figure 5A), and the amount of IFN-g induced by BCG-infected targets was similar to that induced by activation with the corresponding peptide (see, for comparison, figures 4B and 5A).
The ability of p21-29-and p120-128-specific CD8 ϩ T cell lines to lyse infected target cells was also investigated. Figure 5B shows that CD8 ϩ T cell lines specific for p21-29 and p120-128 peptides efficiently kill BCG-infected THP-1 target cells but have no cytotoxic activity toward uninfected targets. These results indicate that CD8 ϩ T cells recognizing peptides from the 16-kDa protein can efficiently recognize and lyse M. tuberculosis-infected target cells.
Analysis of IFN-g release by freshly isolated CD8 ϩ T cells in response to mycobacterial 16-kDa peptides. To answer the question of whether CD8
ϩ T cell responses are normally elicited during the course of M. tuberculosis infection in vivo and are not the results of artifacts arising from polyclonal or peptidespecific expansion during in vitro cultures, peptides p21-29 and p120-128 were used to assess the level of IFN-g release in CD8 ϩ T cells, using intracellular FACS analysis in fresh PBMC from healthy HLA-A*0201-positive donors or HLA-A*0201-positive subjects with TB.
As shown in figure 6, we were able to detect a statistically significantly higher response in all 8 patients with TB than in healthy control subjects. Moreover, the frequency of IFN-gproducing CD8
ϩ T cells in response to p120-128 was higher than the frequency of IFN-g-producing CD8
ϩ T cells in response to p21-29. These results, obtained using intracellular FACS analysis, clearly demonstrate that the observed CD8 ϩ T cell response to 16-kDa-derived peptides is elicited during the course of M. tuberculosis infection in vivo.
Discussion
Cellular immunity, which involves the interaction between activated infected macrophages and antigen-specific CD4 ϩ T cells, is known to be the major protective response of the human body against infection. This model of defense has long been established as essential for mounting a strong protective immune response against infection with M. tuberculosis [1] . However, it has been suggested, on the basis of observations of experimental TB in mice, that MHC class I-mediated CD8 cytotoxic T cells have a protective role, because mice lacking functional CD8 ϩ T cells were more susceptible to mycobacterial infection [13] [14] [15] .
Human studies have provided evidence that MHC class Irestricted CD8 ϩ T cells recognize M. tuberculosis-infected cells and can release IFN-g, lyse infected target cells, and kill intracellular bacteria [16] [17] [18] . For these reasons, there has been an intense effort to define M. tuberculosis epitopes that can be presented by MHC class I molecules to CD8 ϩ T cells [19] [20] [21] . In the present study, we analyzed the 16-kDa protein of M. tuberculosis to identify HLA-A*0201-binding peptides with the capability of activating CD8 ϩ T cells. We identified 2 new epitopes (p21-29 and p120-128) from the sequence of the 16-kDa protein that are recognized by CD8 ϩ T cells from HLA-A*0201-positive patients with TB. CD8 ϩ T cell responses against these 2 epitopes can also be induced in healthy (uninfected) HLA-A*0201-positive subjects by prolonged stimulation with peptides in vitro, which indicates that both p21-29 and p120-128 can sensitize naive CD8
ϩ T cells and, as a consequence, enable the generation of peptidespecific CTL lines in vitro. Most notably, these peptide-reactive CD8 ϩ T cells killed not only peptide-pulsed target cells but also M. tuberculosis-or BCG-infected HLA-A*0201-positive human macrophages [22] . This suggests that p21-29 and p120-128 epitopes gain entry into mycobacteria-infected host cell cytoplasm, allowing processing and presentation via the MHC class Downloaded from https://academic.oup.com/jid/article-abstract/186/7/991/869226 by guest on 13 December 2018 I pathway. Of interest, immunization of mice with a peptide spanning aa 24-31 of the 16-kDa protein (thus partially overlapping p21-29) induces peptide-specific CD8 ϩ T cells with cytotoxic activity toward peptide-pulsed targets [23] .
Finally, using an intracellular assay for assessing IFN-g production to measure peptide-specific CD8 ϩ T cell frequencies, we demonstrated that CD8 ϩ T cell responses to p21-29 and p120-128 are detected ex vivo in freshly isolated PBMC from patients with TB but not in those from healthy control subjects, which indicates that the CD8 ϩ T cell response to 16-kDa-derived peptides is elicited during the course of M. tuberculosis infection in vivo [24] .
There are at least 3 possible pathways by which these CD8 ϩ T cells can play a critical role in the immune response against M. tuberculosis infection: the release of IFN-g, lysis of the infected target, and direct antimicrobial activity [14, 19] . In our study, M. tuberculosis peptide-reactive CD8 ϩ T cell lines release IFN-g and TNF-a on recognition of peptide-pulsed cells, providing a mechanism by which this T cell subset might contribute to immunity against M. tuberculosis infection. In fact, IFN-g and TNF-a synergize for the induction of inducible nitric oxide synthase and production of nitric oxide from macrophages, which, in turn, exerts cytocidal effects on intracellular bacteria such as M. tuberculosis.
The second mechanism by which MHC class I-restricted T cells can contribute to host defense against M. tuberculosis infection is their ability to lyse infected target cells [22, 23, 25, 26] . CD8 ϩ T cells specific for the p21-29 and p120-128 peptides of the 16-kDa protein lysed TB-infected targets of the monocyte/macrophage lineage. The continued lysis of infected cells could lead to release of bacteria from this safe intracellular harbor so that they can be taken up at a low multiplicity by freshly activated macrophages and destroyed [27] .
Ultimately, CD8 ϩ T cells can mediate antimicrobial activity by the release of perforin and granulysin from cytotoxic granules that can directly kill the intracellular microbial pathogen [5] . In our study, the presence of both perforin and granulysin in these CD8 ϩ T cells was demonstrated by intracellular staining. Granulysin, which is homologous to the saposin-like protein family of lipid-binding proteins, exerts its cytolytic function and antibacterial activity via interaction with lipids that induce lesions on the surface of M. tuberculosis with a direct action on the mycobacterial glycolipid envelope [28, 29] . Perforin colocalizes in the cytotoxic granules of CD8 ϩ T cells and is released, together with granulysin, when antigen activation occurs. Perforin forms pores in the membranes of infected cells and shows no antibacterial activity when isolated, whereas the combination of both molecules resulted in a dramatic decrease in the viability of intracellular mycobacteria [5] .
In conclusion, we have demonstrated that human MHC class I-restricted CD8 ϩ T cells specific for epitopes of the 16-kDa antigen from M. tuberculosis play a critical role in the immunologic response against mycobacterial infections. The presence of peptide-specific CD8 ϩ T cells in patients with TB suggests that these epitopes are presented during the natural course of infection [19] . Our data have demonstrated that these cells can also be induced in healthy HLA-A*0201-positive subjects, which suggests that these epitopes may be useful for immunoprophylaxis against TB infection.
